Copyright Reports & Markets. All rights reserved.

Global and United States Herpes Zoste Drug Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Herpes Zoste Drug Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Herpes Zoste Drug Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Herpes Zoste Drug Market Size Growth Rate by Type
    • 1.4.2 Acyclovir
    • 1.4.3 Amenamevir
    • 1.4.4 FV-100
    • 1.4.5 GLS-5100
    • 1.4.6 GSK-1437173A
    • 1.4.7 NAL-3221
    • 1.4.8 Others
  • 1.5 Market by Application
    • 1.5.1 Global Herpes Zoste Drug Market Size Growth Rate by Application
    • 1.5.2 Clinic
    • 1.5.3 Hospital
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Herpes Zoste Drug Market Size, Estimates and Forecasts
    • 2.1.1 Global Herpes Zoste Drug Revenue 2015-2026
    • 2.1.2 Global Herpes Zoste Drug Sales 2015-2026
  • 2.2 Global Herpes Zoste Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Herpes Zoste Drug Historical Market Size by Region (2015-2020)
    • 2.3.1 Global Herpes Zoste Drug Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.3.2 Global Herpes Zoste Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 2.4 Herpes Zoste Drug Market Estimates and Projections by Region (2021-2026)
    • 2.4.1 Global Herpes Zoste Drug Sales Forecast by Region (2021-2026)
    • 2.4.2 Global Herpes Zoste Drug Revenue Forecast by Region (2021-2026)

3 Global Herpes Zoste Drug Competitor Landscape by Players

  • 3.1 Global Top Herpes Zoste Drug Sales by Manufacturers
    • 3.1.1 Global Herpes Zoste Drug Sales by Manufacturers (2015-2020)
    • 3.1.2 Global Herpes Zoste Drug Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Global Herpes Zoste Drug Manufacturers by Revenue
    • 3.2.1 Global Herpes Zoste Drug Revenue by Manufacturers (2015-2020)
    • 3.2.2 Global Herpes Zoste Drug Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Herpes Zoste Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Herpes Zoste Drug Revenue in 2019
    • 3.2.5 Global Herpes Zoste Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Global Herpes Zoste Drug Price by Manufacturers
  • 3.4 Global Herpes Zoste Drug Manufacturing Base Distribution, Product Types
    • 3.4.1 Herpes Zoste Drug Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Herpes Zoste Drug Product Type
    • 3.4.3 Date of International Manufacturers Enter into Herpes Zoste Drug Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Herpes Zoste Drug Market Size by Type (2015-2020)
    • 4.1.1 Global Herpes Zoste Drug Sales by Type (2015-2020)
    • 4.1.2 Global Herpes Zoste Drug Revenue by Type (2015-2020)
    • 4.1.3 Herpes Zoste Drug Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Herpes Zoste Drug Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Herpes Zoste Drug Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Herpes Zoste Drug Revenue Forecast by Type (2021-2026)
    • 4.2.3 Herpes Zoste Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Herpes Zoste Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Herpes Zoste Drug Market Size by Application (2015-2020)
    • 5.1.1 Global Herpes Zoste Drug Sales by Application (2015-2020)
    • 5.1.2 Global Herpes Zoste Drug Revenue by Application (2015-2020)
    • 5.1.3 Herpes Zoste Drug Price by Application (2015-2020)
  • 5.2 Herpes Zoste Drug Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Herpes Zoste Drug Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Herpes Zoste Drug Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Herpes Zoste Drug Price Forecast by Application (2021-2026)

6 United States by Players, Type and Application

  • 6.1 United States Herpes Zoste Drug Market Size YoY Growth 2015-2026
    • 6.1.1 United States Herpes Zoste Drug Sales YoY Growth 2015-2026
    • 6.1.2 United States Herpes Zoste Drug Revenue YoY Growth 2015-2026
    • 6.1.3 United States Herpes Zoste Drug Market Share in Global Market 2015-2026
  • 6.2 United States Herpes Zoste Drug Market Size by Players (International and Local Players)
    • 6.2.1 United States Top Herpes Zoste Drug Players by Sales (2015-2020)
    • 6.2.2 United States Top Herpes Zoste Drug Players by Revenue (2015-2020)
  • 6.3 United States Herpes Zoste Drug Historic Market Review by Type (2015-2020)
    • 6.3.1 United States Herpes Zoste Drug Sales Market Share by Type (2015-2020)
    • 6.3.2 United States Herpes Zoste Drug Revenue Market Share by Type (2015-2020)
    • 6.3.3 United States Herpes Zoste Drug Price by Type (2015-2020)
  • 6.4 United States Herpes Zoste Drug Market Estimates and Forecasts by Type (2021-2026)
    • 6.4.1 United States Herpes Zoste Drug Sales Forecast by Type (2021-2026)
    • 6.4.2 United States Herpes Zoste Drug Revenue Forecast by Type (2021-2026)
    • 6.4.3 United States Herpes Zoste Drug Price Forecast by Type (2021-2026)
  • 6.5 United States Herpes Zoste Drug Historic Market Review by Application (2015-2020)
    • 6.5.1 United States Herpes Zoste Drug Sales Market Share by Application (2015-2020)
    • 6.5.2 United States Herpes Zoste Drug Revenue Market Share by Application (2015-2020)
    • 6.5.3 United States Herpes Zoste Drug Price by Application (2015-2020)
  • 6.6 United States Herpes Zoste Drug Market Estimates and Forecasts by Application (2021-2026)
    • 6.6.1 United States Herpes Zoste Drug Sales Forecast by Application (2021-2026)
    • 6.6.2 United States Herpes Zoste Drug Revenue Forecast by Application (2021-2026)
    • 6.6.3 United States Herpes Zoste Drug Price Forecast by Application (2021-2026)

7 North America

  • 7.1 North America Herpes Zoste Drug Market Size YoY Growth 2015-2026
  • 7.2 North America Herpes Zoste Drug Market Facts & Figures by Country
    • 7.2.1 North America Herpes Zoste Drug Sales by Country (2015-2020)
    • 7.2.2 North America Herpes Zoste Drug Revenue by Country (2015-2020)
    • 7.2.3 U.S.
    • 7.2.4 Canada

8 Europe

  • 8.1 Europe Herpes Zoste Drug Market Size YoY Growth 2015-2026
  • 8.2 Europe Herpes Zoste Drug Market Facts & Figures by Country
    • 8.2.1 Europe Herpes Zoste Drug Sales by Country
    • 8.2.2 Europe Herpes Zoste Drug Revenue by Country
    • 8.2.3 Germany
    • 8.2.4 France
    • 8.2.5 U.K.
    • 8.2.6 Italy
    • 8.2.7 Russia

9 Asia Pacific

  • 9.1 Asia Pacific Herpes Zoste Drug Market Size YoY Growth 2015-2026
  • 9.2 Asia Pacific Herpes Zoste Drug Market Facts & Figures by Country
    • 9.2.1 Asia Pacific Herpes Zoste Drug Sales by Region (2015-2020)
    • 9.2.2 Asia Pacific Herpes Zoste Drug Revenue by Region
    • 9.2.3 China
    • 9.2.4 Japan
    • 9.2.5 South Korea
    • 9.2.6 India
    • 9.2.7 Australia
    • 9.2.8 Taiwan
    • 9.2.9 Indonesia
    • 9.2.10 Thailand
    • 9.2.11 Malaysia
    • 9.2.12 Philippines
    • 9.2.13 Vietnam

10 Latin America

  • 10.1 Latin America Herpes Zoste Drug Market Size YoY Growth 2015-2026
  • 10.2 Latin America Herpes Zoste Drug Market Facts & Figures by Country
    • 10.2.1 Latin America Herpes Zoste Drug Sales by Country
    • 10.2.2 Latin America Herpes Zoste Drug Revenue by Country
    • 10.2.3 Mexico
    • 10.2.4 Brazil
    • 10.2.5 Argentina

11 Middle East and Africa

  • 11.1 Middle East and Africa Herpes Zoste Drug Market Size YoY Growth 2015-2026
  • 11.2 Middle East and Africa Herpes Zoste Drug Market Facts & Figures by Country
    • 11.2.1 Middle East and Africa Herpes Zoste Drug Sales by Country
    • 11.2.2 Middle East and Africa Herpes Zoste Drug Revenue by Country
    • 11.2.3 Turkey
    • 11.2.4 Saudi Arabia
    • 11.2.5 U.A.E

12 Company Profiles

  • 12.1 Astellas Pharma Inc.
    • 12.1.1 Astellas Pharma Inc. Corporation Information
    • 12.1.2 Astellas Pharma Inc. Description and Business Overview
    • 12.1.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.1.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
    • 12.1.5 Astellas Pharma Inc. Recent Development
  • 12.2 Beijing Minhai Biotechnology Co., Ltd
    • 12.2.1 Beijing Minhai Biotechnology Co., Ltd Corporation Information
    • 12.2.2 Beijing Minhai Biotechnology Co., Ltd Description and Business Overview
    • 12.2.3 Beijing Minhai Biotechnology Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 12.2.4 Beijing Minhai Biotechnology Co., Ltd Herpes Zoste Drug Products Offered
    • 12.2.5 Beijing Minhai Biotechnology Co., Ltd Recent Development
  • 12.3 ContraVir Pharmaceuticals, Inc.
    • 12.3.1 ContraVir Pharmaceuticals, Inc. Corporation Information
    • 12.3.2 ContraVir Pharmaceuticals, Inc. Description and Business Overview
    • 12.3.3 ContraVir Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.3.4 ContraVir Pharmaceuticals, Inc. Herpes Zoste Drug Products Offered
    • 12.3.5 ContraVir Pharmaceuticals, Inc. Recent Development
  • 12.4 Epiphany Biosciences, Inc.
    • 12.4.1 Epiphany Biosciences, Inc. Corporation Information
    • 12.4.2 Epiphany Biosciences, Inc. Description and Business Overview
    • 12.4.3 Epiphany Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.4.4 Epiphany Biosciences, Inc. Herpes Zoste Drug Products Offered
    • 12.4.5 Epiphany Biosciences, Inc. Recent Development
  • 12.5 Foamix Pharmaceuticals Ltd.
    • 12.5.1 Foamix Pharmaceuticals Ltd. Corporation Information
    • 12.5.2 Foamix Pharmaceuticals Ltd. Description and Business Overview
    • 12.5.3 Foamix Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 12.5.4 Foamix Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
    • 12.5.5 Foamix Pharmaceuticals Ltd. Recent Development
  • 12.6 GeneOne Life Science, Inc.
    • 12.6.1 GeneOne Life Science, Inc. Corporation Information
    • 12.6.2 GeneOne Life Science, Inc. Description and Business Overview
    • 12.6.3 GeneOne Life Science, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.6.4 GeneOne Life Science, Inc. Herpes Zoste Drug Products Offered
    • 12.6.5 GeneOne Life Science, Inc. Recent Development
  • 12.7 GlaxoSmithKline Plc
    • 12.7.1 GlaxoSmithKline Plc Corporation Information
    • 12.7.2 GlaxoSmithKline Plc Description and Business Overview
    • 12.7.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
    • 12.7.4 GlaxoSmithKline Plc Herpes Zoste Drug Products Offered
    • 12.7.5 GlaxoSmithKline Plc Recent Development
  • 12.8 Merck & Co., Inc.
    • 12.8.1 Merck & Co., Inc. Corporation Information
    • 12.8.2 Merck & Co., Inc. Description and Business Overview
    • 12.8.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.8.4 Merck & Co., Inc. Herpes Zoste Drug Products Offered
    • 12.8.5 Merck & Co., Inc. Recent Development
  • 12.9 NAL Pharmaceuticals Ltd.
    • 12.9.1 NAL Pharmaceuticals Ltd. Corporation Information
    • 12.9.2 NAL Pharmaceuticals Ltd. Description and Business Overview
    • 12.9.3 NAL Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 12.9.4 NAL Pharmaceuticals Ltd. Herpes Zoste Drug Products Offered
    • 12.9.5 NAL Pharmaceuticals Ltd. Recent Development
  • 12.10 ReceptoPharm, Inc.
    • 12.10.1 ReceptoPharm, Inc. Corporation Information
    • 12.10.2 ReceptoPharm, Inc. Description and Business Overview
    • 12.10.3 ReceptoPharm, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.10.4 ReceptoPharm, Inc. Herpes Zoste Drug Products Offered
    • 12.10.5 ReceptoPharm, Inc. Recent Development
  • 12.11 Astellas Pharma Inc.
    • 12.11.1 Astellas Pharma Inc. Corporation Information
    • 12.11.2 Astellas Pharma Inc. Description and Business Overview
    • 12.11.3 Astellas Pharma Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 12.11.4 Astellas Pharma Inc. Herpes Zoste Drug Products Offered
    • 12.11.5 Astellas Pharma Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Herpes Zoste Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Herpes Zoste Drug Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Herpes Zoste Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Zoste Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Segment by Type, the Herpes Zoste Drug market is segmented into
    Acyclovir
    Amenamevir
    FV-100
    GLS-5100
    GSK-1437173A
    NAL-3221
    Others

    Segment by Application, the Herpes Zoste Drug market is segmented into
    Clinic
    Hospital
    Others

    Regional and Country-level Analysis
    The Herpes Zoste Drug market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Herpes Zoste Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

    Competitive Landscape and Herpes Zoste Drug Market Share Analysis
    Herpes Zoste Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Zoste Drug business, the date to enter into the Herpes Zoste Drug market, Herpes Zoste Drug product introduction, recent developments, etc.
    The major vendors covered:
    Astellas Pharma Inc.
    Beijing Minhai Biotechnology Co., Ltd
    ContraVir Pharmaceuticals, Inc.
    Epiphany Biosciences, Inc.
    Foamix Pharmaceuticals Ltd.
    GeneOne Life Science, Inc.
    GlaxoSmithKline Plc
    Merck & Co., Inc.
    NAL Pharmaceuticals Ltd.
    ReceptoPharm, Inc.
    TSRL, Inc.

    Buy now